hmpl-a251
hmpl-a251: 1 clinical trial tracked.
hmpl-a251 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about hmpl-a251, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Phase Ⅰ/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A251 in Participants With Advanced or Metastatic HER2-Expressing Solid Tumors
Primary endpoint: Maximum Tolerated Dose (MTD)
InterventionalRandomizedopen147 targetStarted 2025-12Completion 2028-1215 sites · China, United StatesHutchmed